🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

María Reig

Hospital Clínic de Barcelona

ORCID: 0000-0002-5711-9534

Also affiliated with Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 11 papers. Top paper: “Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study”.

Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study

JHEP Reports(2025)10.1016/j.jhepr.2025.101685
N/A
0.165DataRank · unranked
2 citations

Tiziana Pressiani, Naoshi Nishida, Shadi Chamseddine, Ashwini Arvind, Michael Li +36 more

Interim analysis of the ACTION trial: Cabozantinib for hepatocellular carcinoma patients who discontinued first line treatment other than sorafenib or due to sorafenib intolerance

Journal of Hepatology(2023)10.1016/s0168-8278(23)01381-8
N/A
0.104DataRank · unranked
1 citations

Sergio Muñoz Martinez, Mariona Calvo, Maria Varela, Neus Llarch, Gemma Iserte +13 more

Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity

Cell Death and Disease(2021)10.1038/s41419-021-03827-0
N/A
0DataRank · unranked
28 citations

Rubén Rodríguez‐Agudo, David Fernández‐Ramos, Lucía Barbier‐Torres, Imanol Zubiete‐Franco, Sergio López de Davalillo +26 more

HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

Journal of Hepatology(2022)10.1016/j.jhep.2022.01.023
N/A
0DataRank · unranked
422 citations

Emily Zhang, Manasa Narasimman, Nicole E. Rich, Akbar K. Waljee, Yujin Hoshida +7 more

Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes

Human Molecular Genetics(2023)10.1093/hmg/ddad099
N/A
0DataRank · unranked
11 citations

Michael G. Heckman, Launia J. White, Irene K. Yan, Vivekananda Sarangi, Kimberly P. Lauer +19 more

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Journal of Hepatology(2021)10.1016/j.jhep.2021.11.018
N/A
0DataRank · unranked
4206 citations

Alejandro Forner, Jordi Rimola, Joana Ferrer, Marta Burrel, Ángeles García‐Criado +11 more

Evidence and choice: The BCLC vision for tailoring clinical decision-making

Journal of Hepatology(2024)10.1016/j.jhep.2024.04.023
N/A
0DataRank · unranked
3 citations

Alejandro Forner, Jordi Rimola, Joana Ferrer, Marta Burrel, Ángeles García‐Criado +11 more

Association of Epigenetic Aging Biomarkers With Risk of MASLD ‐Related HCC

Liver International(2025)10.1111/liv.70464
N/A
0DataRank · unranked
3 citations

Sebastian M. Armasu, Winnie Z. Fan, Naana N. Yalley, Irene K. Yan, Fowsiyo Ahmed +14 more

Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer

Gastro Hep Advances(2025)10.1016/j.gastha.2025.100621
N/A
0DataRank · unranked
3 citations

Ampem Darko Jnr Siaw, Sebastian M. Armasu, Jacob A. Frank, Irene K. Yan, Fowsiyo Ahmed +12 more

Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus

Practical Radiation Oncology(2024)10.1016/j.prro.2023.08.016
N/A
0DataRank · unranked
18 citations

Joel E. Tepper, Andrew M. Moon, Aisling Barry, Meritxell Mollà, Jinsil Seong +33 more

First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials

Liver Cancer(2021)10.1159/000520278
N/A
0DataRank · unranked
50 citations

María Reig, Ciro Celsa, Ferràn Torres, Salvatore Battaglia, Marco Enea +9 more